By contrast, countries like India, which do not award patent term extensions, could see generic competition entering much sooner once the patents on the main compound expire there in 2026
These pills should cost less than the injectables Pills tend to be cheaper than injectables, so patients are hoping they'll be more affordable than the brand-name injected medicines with list prices of over $1,000 a month and that insurance companies will be more likely to cover them
22,23 The magnitude of weight loss (and its association with GLP-1 RA discontinuation) has largely been omitted from previous analyses
I gave it a try at a very, very low dose
Most patients report feeling full faster and staying full longer
DA3-CH was superior to liraglutide [149]